Sweden reduces criteria for diabetes diagnosis:
This article was originally published in Clinica
Sweden's National Board of Health and Welfare has approved new guidelines lowering the cut-off point at which a diabetes diagnosis is made. The level at which fasting plasma glucose triggers a diagnosis of diabetes is to be reduced from 6.7 to 6.1 mmol/l, increasing the number of diabetics in Sweden by 7%-8% (see Clinica No 826, p 5). The guidelines should have gone into effect at the end of last year, but they are now expected to be introduced in August, according to Claes Mebius, director of the National Board of Health and Welfare.
You may also be interested in...
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.
Sabinsa provided FDA and FTC with documentation of “an ingredient falsely marketed and sold as vitamin C derived from amla fruit (Emblica officinalis), which two independent labs have confirmed is actually derived from corn, sugarcane or other plants.”